InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Explore the full record of transactions filed by Komjathy Andrew, Directeur Commercial. Director active across 1 company, notably Astria Therapeutics, Inc.. Aggregated, 2 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €589. Activity tracked since 19 November 2021. The latest transaction was disclosed on 19 November 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Komjathy Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10 sharesCommon StockSEC:0000905148-26-000319:0
100 shares@ US$6.695100.0% of flowCommon StockSEC:0001104659-21-143035:0
Canonical exit: 17 Feb 2022 (T+90)
2 of 2 declarations
About Komjathy Andrew
Komjathy Andrew is the Chief Commercial Officer at Astria Therapeutics, Inc. He oversees commercial operations and contributes to the company's growth strategy.
